![Michael Hayden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Hayden
Directeur/Membre du Conseil chez
ABCELLERA BIOLOGICS INC.
Fortune : 14 M $ au 31/05/2026
Profil
Michael R.
Hayden founded Aspreva Pharmaceuticals Corp.
in 2002, where he worked as Director from 2002 to 2007, Centre for Molecular Medicine & Therapeutic in 1992, where he worked as Director from 1992 to 2012, Xenon Pharmaceuticals, Inc. in 1996, where he worked as Independent Director from 2012 to 2022, and 89bio, Inc. in 2018, where he worked as Independent Director from 2018 to 2025.
Dr. Hayden also founded NeuroVir Therapeutic, Inc., Prilenia Therapeutics Development Ltd., and Prilenia Therapeutics BV, where he is working as Chief Executive Officer.
Dr. Hayden also currently works at Ionis Pharmaceuticals, Inc., as Independent Director from 2018, National University of Singapore, as Director-Translational Laboratory, Canadian Genetics Diseases Network, as Scientific Director from 1990, Royal Society of Canada, as Director from 1995, AbCellera Biologics, Inc., as Lead Independent Director from 2019, Translational Laboratory in Genetic Medicine, as Director & Program Director, Andera Partners SCA, as Venture Advisor from 2018, the University of British Columbia, as Professor from 1991, Forbion Capital Partners Management Holding BV, as Venture Partner from 2022, and American Society of Clinical Investigation, as Member from 1992.
Dr. Hayden also formerly worked at Lycera Corp., as Director, Many Bright Ideas Technologies, Inc., as Director in 2010, Agency for Science, Technology & Research, as Director, Michael Smith Foundation for Health Research, as Director from 2011 to 2012, Aurinia Pharmaceuticals, Inc., as Independent Director from 2018 to 2021, Oxford Biomedica Plc, as Non-Executive Director from 2021 to 2024, Teva Pharmaceutical Industries Ltd., as Chief Scientific Officer from 2013 to 2017, American Society of Human Genetics, as Member from 1994 to 2010, and GlobaR&D Co. ,Ltd, as President & Chief Scientific Officer.
Dr. Hayden received his undergraduate degree in 1975 and doctorate degree in 1979 from the University of Cape Town.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 1 441 642 ( 0,47 % ) | 9 M $ | 31/05/2026 | |
| 31/03/2026 | 56 298 ( 0,03 % ) | 4 M $ | 31/05/2026 | |
OXFORD BIOMEDICA PLC 0,03 % | 31/12/2024 | 39 973 ( 0,03 % ) | 338 377 $ | 31/05/2026 |
Postes actifs de Michael Hayden
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 24/09/2018 |
| ABCELLERA BIOLOGICS INC. | Directeur/Membre du Conseil | 01/10/2019 |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partner invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Consultant / Advisor | 01/01/2018 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 31/03/2022 |
Prilenia Therapeutics BV
 Prilenia Therapeutics BV BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Directeur Général | - |
National University of Singapore
 National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Society of Clinical Investigation | Corporate Officer/Principal | 01/01/1992 |
Translational Laboratory in Genetic Medicine | Directeur/Membre du Conseil | - |
Royal Society of Canada
 Royal Society of Canada Miscellaneous Commercial ServicesCommercial Services Engages in offering educational courses | Directeur/Membre du Conseil | 28/12/2010 |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Michael Hayden
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Hayden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partner invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Many Bright Ideas Technologies, Inc.
 Many Bright Ideas Technologies, Inc. Medical/Nursing ServicesHealth Services Develops genetic content for molecular diagnostic tests | Health Services |
Agency for Science, Technology & Research
 Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Fosters scientific research and development | Commercial Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous Operates as health research funding agency | Miscellaneous |
American Society of Human Genetics
 American Society of Human Genetics Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for human geneticists | Commercial Services |
American Society of Clinical Investigation | |
Canadian Genetics Diseases Network
 Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Engages in research and development of genetic discoveries to prevent diagnose diseases | Commercial Services |
Royal Society of Canada
Royal Society of Canada Miscellaneous Commercial ServicesCommercial Services Engages in offering educational courses | Commercial Services |
Centre for Molecular Medicine & Therapeutic
 Centre for Molecular Medicine & Therapeutic The Centre for Molecular Medicine & Therapeutics operates within the University of British Columbia and is part of the university’s broader efforts in medical research and education, including advancing medical treatments through AI development and fostering academic collaborations. The private company is based in Vancouver, Canada. The Canadian company was founded by Michael R. Hayden. | |
NeuroVir Therapeutic, Inc.
 NeuroVir Therapeutic, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Translational Laboratory in Genetic Medicine | |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Prilenia Therapeutics Development Ltd.
 Prilenia Therapeutics Development Ltd. Miscellaneous Commercial ServicesCommercial Services Operates clinical stage biotech company | Commercial Services |
Prilenia Therapeutics BV
Prilenia Therapeutics BV BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
GlobaR&D Co. ,Ltd |
